|
Syndicate
|
The deal size was… The deal size was increased to $875M in common stock from $750M in common stock. JPMorgan and BofA acted as joint book running managers for the offering. ShowHide Related Items >><< - 05/15/20
- Third Point adds Disney, exits Campbell Soup in Q1
- 05/08/20
- Boston Scientific' Emblem defibrillator system meets primary endpoint
- 05/08/20
- Boston Scientific' Watchman device meets safety and efficacy endpoints
- 04/23/20
- UnitedHealth, Boston Scientific, Medtronic to deploy 3,000 ventilator devices
- 05/10/20 Piper Sandler
- FLX to further strengthen Boston category leadership in LAAC, says Piper Sandler
- 04/28/20 Piper Sandler
- Untreated heart attacks negative for Abiomed, says Piper Sandler
- 04/22/20 SVB Leerink
- Boston Scientific downgraded to Market Perform at SVB Leerink on slower recovery
- 04/22/20 SVB Leerink
- Boston Scientific downgraded to Market Perform from Outperform at SVB Leerink
- 04/29/20
- Boston Scientific unable to estimate overall impacts on FY20 financial results
- 04/29/20
- Boston Scientific reports Q1 adj. EPS 28c, consensus 31c
- 04/28/20
- Notable companies reporting before tomorrow's open
|
|
On The Fly
|
Check out this morning's… ShowHide Related Items >><< - 05/20/20
- Take-Two says 'Kerbal Space Program 2' delayed due to COVID-19
- 05/20/20
- Take-Two has 'array of titles' set to launch in FY22
- 05/20/20
- Take-Two says Q4 results 'significantly better than expected'
- 05/20/20
- TakeTwo Interactive Software trading resumes
- 04/02/20
- Teekay Tankers falls -18.0%
- 01/28/20
- Teekay Tankers sells three vessels for approximately $57M
- 01/28/20
- Teekay Tankers sells non-U.S. ship-to-ship transfer business
- 05/21/20
- TJX up 2.5% after reporting Q1 results, store reopenings
- 05/21/20
- TJX announces store reopenings
- 04/07/20
- TJX says store closures to hurt liquidity, furloughs to start after April 11
- 04/07/20
- TJX CEO, Executive Chairman salaries to be reduced by 30%
- 05/11/20
- Teekay LNG, Teekay announce elimination of incentive distribution rights
- 04/16/20
- Teekay LNG increases quarterly cash distribution 32% to 25c per share
- 01/20/20
- Teekay LNG Partners declares distribution of 19c per common unit
- 05/21/20
- Medtronic seeing early signs of recovery, sees Q1 as 'trough'
- 05/21/20
- Medtronic won't buy growth, would do tuck-in M&A
- 05/21/20
- Medtronic: Q1 gross margin could be down 'a few points' sequentially
- 05/21/20
- Medtronic sees gross margin remaining under pressure
- 05/21/20
- Kadmon announces topline results from ROCKstar trial primary analysis
- 04/14/20
- Kadmon announces receipt of final meeting minutes from FDA
- 03/13/20
- Kadmon sees receiving final minutes from pre-NDA meeting within 30 days
- 03/05/20
- Fly Intel: After Hours Movers
- 05/08/20
- Jennie-O Turkey Store reopens Melrose, Minnesota facility
- 05/07/20
- Jennie-O Turkey Store to reopen Willmar facility
- 05/04/20
- Don Miguel Foods to reopen as scheduled on May 4
- 04/28/20
- Hormel Foods's Jennie-O Turkey Store to pause operations at Melrose, MN plant
- 05/20/20
- Expedia sees Q2 adjusted EBITDA significantly lower than Q1
- 05/20/20
- Expedia jumps 3.4% after Q1 results
- 05/20/20
- Expedia reports Q1 adjusted EBITDA ($76M) vs. $176M a year ago
- 05/20/20
- Expedia 'suffered a major reduction in business' since start of COVID-19
- 05/15/20
- Third Point adds Disney, exits Campbell Soup in Q1
- 05/08/20
- Boston Scientific' Emblem defibrillator system meets primary endpoint
- 05/08/20
- Boston Scientific' Watchman device meets safety and efficacy endpoints
- 04/23/20
- UnitedHealth, Boston Scientific, Medtronic to deploy 3,000 ventilator devices
- 05/21/20
- BJ's Wholesale reports Q1 adjusted EBITDA up 56.3% to $193.9M
- 04/03/20
- BJ's Wholesale to check temperatures of team members as they report to work
- 03/23/20
- BJ's Wholesale announces dedicated hours for members age 60 and over
- 03/23/20
- BJ's Wholesale increases wages by $2 per hour, announces one-time bonuses
- 05/21/20
- Best Buy says has retained 95% of sales in first two weeks in May
- 05/21/20
- Best Buy lowers FY21 CapEx view to $650M-$750M from $800M-$900M
- 05/21/20
- Best Buy expects Q2 sales rate 'to be pressured'
- 05/21/20
- Best Buy says 'still a high level of uncertainty at macro, micro level'
- 05/19/20 Raymond James
- Kadmon initiated with an Outperform at Raymond Jame
- 05/19/20 Raymond James
- Kadmon initiated with an Outperform at Raymond James
- 03/16/20 Nomura Instinet
- Kadmon news of FDA meeting a positive, says Nomura Instinet
- 01/10/20 Nomura Instinet
- Kadmon initiated with a Buy at Nomura Instinet
- 10/02/19
- Teekay Corp. Investor Day has been postponed
- 03/09/20 DNB Markets
- Teekay Tankers downgraded to Hold from Buy at DNB Markets
- 11/18/19 BofA
- Teekay Tankers upgraded two notches to Buy from Underperform at BofA/Merrill
- 11/18/19 BofA
- Teekay Tankers upgraded to Buy from Underperform at BofA/Merrill
- 10/23/19 Jefferies
- Jefferies upgrades Teekay Tankers to Buy, boosts target to $2.50 from $1.50
- 05/14/20 Credit Suisse
- BJ's Wholesale price target raised to $31 from $26 at Credit Suisse
- 05/01/20 JPMorgan
- Ulta Beauty, BJ's best near-term picks in retail, says JPMorgan
- 04/15/20 Citi
- BJ's Wholesale assumed with a Neutral from Buy at Citi
- 04/14/20 Loop Capital
- BJ's Wholesale price target raised to $35 from $30 at Loop Capital
- 05/21/20 Credit Suisse
- Expedia price target raised to $101 from $90 at Credit Suisse
- 05/21/20 Deutsche Bank
- Expedia price target raised to $112 from $87 at Deutsche Bank
- 05/21/20 Benchmark
- Expedia price target lowered to $103 from $155 at Benchmark
- 05/21/20 RBC Capital
- Expedia price target raised to $90 from $71 at RBC Capital
- 04/29/20
- Fly Intel: Top five analyst downgrades
- 04/29/20 Piper Sandler
- Hormel downgraded to Neutral on foodservice risk at Piper Sandler
- 04/28/20 Piper Sandler
- Hormel Foods downgraded to Neutral from Overweight at Piper Sandler
- 03/26/20
- Fly Intel: Top five analyst upgrades
- 05/14/20 DZ Bank
- Medtronic downgraded to Hold from Buy at DZ Bank
- 04/28/20 Piper Sandler
- Untreated heart attacks negative for Abiomed, says Piper Sandler
- 04/22/20 Wells Fargo
- Medtronic price target lowered to $108 from $130 at Wells Fargo
- 04/09/20 Raymond James
- Medtronic price target lowered to $110 from $122 at Raymond James
- 05/18/20
- Fly Intel: Top five analyst upgrades
- 05/18/20 Telsey Advisory
- Best Buy upgraded to Outperform from Market Perform at Telsey Advisory
- 05/14/20
- Fly Intel: Top five analyst upgrades
- 05/14/20 Wells Fargo
- Best Buy price target raised to $75 from $60 at Wells Fargo
- 05/19/20 Jefferies
- TJX to benefit from 'biggest liquidation sale in history,' says Jefferies
- 05/11/20 Nomura Instinet
- TJX price target raised to $59 from $56 at Nomura Instinet
- 05/04/20 Barclays
- TJX price target lowered to $60 from $74 at Barclays
- 04/29/20
- Fly Intel: Top five analyst upgrades
- 05/21/20 Wedbush
- Take-Two price target raised to $170 from $131 at Wedbush
- 05/21/20 MKM Partners
- Take-Two price target raised to $145 from $124 at MKM Partners
- 05/21/20 Oppenheimer
- Take-Two price target raised to $155 from $145 at Oppenheimer
- 05/21/20 Morgan Stanley
- Take-Two price target raised to $150 from $140 at Morgan Stanley
- 05/10/20 Piper Sandler
- FLX to further strengthen Boston category leadership in LAAC, says Piper Sandler
- 04/22/20 SVB Leerink
- Boston Scientific downgraded to Market Perform at SVB Leerink on slower recovery
- 04/22/20 SVB Leerink
- Boston Scientific downgraded to Market Perform from Outperform at SVB Leerink
- 05/20/20
- Take-Two sees FY21 EPS $2.60-$2.85, consensus $4.34
- 05/20/20
- Take-Two sees Q1 EPS 90c-$1.00, consensus 50c
- 05/20/20
- Take-Two reports Q4 EPS $1.07, consensus 89c
- 05/21/20
- Teekay Tankers reports Q1 adj. EPS $3.27, consensus $2.66
- 02/27/20
- Teekay Tankers reports Q4 adj. EPS $2.47, consensus $2.04
- 05/21/20
- TJX not providing FY21 guidance at this time
- 05/21/20
- TJX reports Q1 EPS (74c), consensus (15c)
- 03/19/20
- TJX withdraws Q1, FY21 financial guidance
- 02/26/20
- TJX sees Q1 revenue $9.8B-$9.9B, consensus $9.84B
- 05/21/20
- Teekay LNG reports Q1 adj. EPS 58c, consensus 66c
- 02/27/20
- Teekay LNG reports Q4 adj. EPS 56c, consensus 59c
- 05/21/20
- Medtronic not providing guidance at this time
- 05/21/20
- Medtronic reports Q4 adjusted EPS 58c, consensus $1.06
- 02/24/20
- IntriCon reports Q4 EPS 8c, consensus (4c)
- 02/18/20
- Medtronic sees Q4 organic revenue growth approximately 4.5%, consensus $8.5B
- 05/07/20
- Kadmon reports Q1 EPS (19c), consensus (14c)
- 03/05/20
- Kadmon reports Q4 EPS (9c), consensus (21c)
- 05/21/20
- Hormel Foods withdraws FY20 guidance due to COVID-19
- 05/21/20
- Hormel Foods reports Q2 adj. EPS 42c, consensus 42c
- 02/20/20
- Hormel Foods backs FY20 EPS view $1.69-$1.83, consensus $1.77
- 02/20/20
- Hormel Foods reports Q1 EPS 45c, consensus 46c
- 05/20/20
- Expedia reports Q1 adjusted EPS ($1.83), consensus ($1.04)
- 05/20/20
- Notable companies reporting after market close
- 02/13/20
- Expedia sees Q1 adjusted EBITDA 'down substantially'
- 02/13/20
- Expedia sees being in 'double-digit' EBITDA territory in FY20
- 04/29/20
- Boston Scientific unable to estimate overall impacts on FY20 financial results
- 04/29/20
- Boston Scientific reports Q1 adj. EPS 28c, consensus 31c
- 04/28/20
- Notable companies reporting before tomorrow's open
- 05/21/20
- BJ's Wholesale reports Q1 adjusted EPS 69c, consensus 34c
- 03/05/20
- BJ's Wholesale sees FY20 EPS $1.55-$1.72, consensus $1.63
- 03/05/20
- BJ's Wholesale reports Q4 adjusted EPS 40c, consensus 40c
- 03/04/20
- Notable companies reporting before tomorrow's open
- 05/21/20
- Best Buy reports Q1 EPS 67c, consensus 60c
- 02/27/20
- Best Buy sees Q1 EPS $1.00-$1.05, consensus $1.01
- 02/27/20
- Best Buy sees FY21 enterprise revenue $43.3B-$44.3B, consensus $44.22B
- 02/27/20
- Best Buy sees FY20 EPS $6.10-$6.30, consensus $6.25
|
|
On The Fly
|
Check out this evening's… ShowHide Related Items >><< - 04/03/20
- Huya announces Tencent's exercise of its option to acquire shares
- 04/03/20
- JOYY announces transfer of Huya shares to Tencent for $262.M in cash
- 03/16/20
- YY reports Q4 global average MAUs 485.2M
- 05/20/20
- Take-Two says 'Kerbal Space Program 2' delayed due to COVID-19
- 05/20/20
- Take-Two has 'array of titles' set to launch in FY22
- 05/20/20
- Take-Two says Q4 results 'significantly better than expected'
- 05/20/20
- TakeTwo Interactive Software trading resumes
- 03/23/20
- Skyline announces 13 facilities suspend operations due to COVID-19
- 01/29/20
- Skyline falls -13.0%
- 01/29/20
- Skyline falls -10.5%
- 01/28/20
- Skyline reports Q3 backlog $133M vs. $181M last year
- 05/20/20
- Shoe Carnival will not buyback any shares in FY20
- 05/20/20
- Shoe Carnival not providing FY20 guidance due to 'considerable uncertainty'
- 05/20/20
- Shoe Carnival CEO says reopened over 80% of stores
- 05/04/20
- Shoe Carnival commences initial store re-openings
- 12/12/19
- scPharmaceuticals announces completion of Furoscix human factors program
- 03/30/20
- Ruth's Hospitality withdraws FY20 guidance, suspends quarterly dividend
- 05/08/20
- Nordson appoints Joseph Kelley as CFO
- 12/12/19
- Nordson announces planned retirement of CFO Gregory Thaxton
- 12/11/19
- Fly Intel: After Hours Movers
- 12/11/19
- Nordson says backlog for the quarter was approximately $385M, down 1% YoY
- 05/15/20
- Soros adds TransDigm stake, boosts Peloton position, exits Mondelez
- 05/15/20
- Monitronics appoints Kevin Lyons as chief people officer
- 04/27/20
- Keurig Dr Pepper up 8% to $27.92 after Q1 results beat estimates
- 04/27/20
- Keurig Dr Pepper CEO says Q1 results 'in line with our long-term targets'
- 04/27/20
- Haverty Furniture trading resumes
- 04/27/20
- Havertys to reduce workforce by approx. 1,200 team members
- 04/27/20
- Havertys plans to reopen 108 stores on May 1
- 04/27/20
- Haverty Furniture trading halted, news pending
- 05/20/20
- Huya sees Q2 revenue up 29.3% to 30.8% from last year
- 01/22/20
- Huya falls -8.5%
- 05/20/20
- Galapagos, Gilead report Phase 2B/3 results from filgotinib study
- 01/23/20
- Galapagos appoints Michele Manto Chief Commercial Officer
- 12/24/19
- Gilead, Eisai enter into agreement in Japan for co-promotion of filgotinib
- 12/05/19
- Galapagos completes recruitment for Phase 2 NOVESA trial
- 05/05/20
- Flexion announces virtual poster presentations for FX201
- 05/01/20
- Flexion announces publication of abstracts on patients treated with ZILRETTA
- 04/27/20
- Flexion announces preclinical data supporting development of FX301
- 04/01/20
- Flexion reconfirms at least 10 months of finished goods available in the U.S.
- 05/20/20
- Expedia sees Q2 adjusted EBITDA significantly lower than Q1
- 05/20/20
- Expedia jumps 3.4% after Q1 results
- 05/20/20
- Expedia reports Q1 adjusted EBITDA ($76M) vs. $176M a year ago
- 05/20/20
- Expedia 'suffered a major reduction in business' since start of COVID-19
- 04/15/20
- Copart chairman sells 462,722 common shares
- 03/24/20
- Copart director sells 70.4K shares of common stock
- 01/14/20
- Copart director Thomas Tryforos sells almost $13M in company shares
- 11/21/19
- Fly Intel: Pre-market Movers
- 04/09/20
- CorePoint Lodging unable to forecast impact from COVID-19
- 04/09/20
- CorePoint Lodging temporarily suspends operations at 26 hotels, reduces staffing
- 04/09/20
- CorePoint Lodging expects to suspend dividend for balance of 2020
- 04/09/20
- CorePoint Lodging implements additional capital preservation measures
- 05/15/20
- Third Point adds Disney, exits Campbell Soup in Q1
- 05/08/20
- Boston Scientific' Emblem defibrillator system meets primary endpoint
- 05/08/20
- Boston Scientific' Watchman device meets safety and efficacy endpoints
- 04/23/20
- UnitedHealth, Boston Scientific, Medtronic to deploy 3,000 ventilator devices
- 05/20/20
- Boot Barn does not provide Q1 or FY21 guidance
- 04/09/20
- Boot Barn withdraws Q4, FY20 guidance
- 02/05/20
- Boot Barn falls -11.8%
- 02/04/20
- Fly Intel: After Hours Movers
- 05/20/20
- Aurora Cannabis up over 26% at $16.12 after announcing Reliva deal
- 05/20/20
- Aurora Cannabis to acquire Reliva for $40M in stock
- 05/20/20
- Aurora Cannabis falls -11.1%
- 05/20/20
- Aurora Cannabis falls -10.9%
- 03/26/20 Wedbush
- Shoe Carnival price target lowered to $25 from $44 at Wedbush
- 03/19/20 Susquehanna
- Shoe Carnival price target lowered to $18 from $47 at Susquehanna
- 11/13/19 Wedbush
- Shoe Carnival price target raised to $42 from $32 at Wedbush
- 10/09/19 Susquehanna
- Shoe Carnival benefiting from competitors struggles, says Susquehanna
- 08/13/19
- Haverty Furniture management to meet with Sidoti
- 05/19/20
- Fly Intel: Top five analyst downgrades
- 05/19/20 Jefferies
- Jefferies downgrades Expedia to Hold on 'long road to recovery'
- 05/19/20 Jefferies
- Expedia downgraded to Hold from Buy at Jefferies
- 05/06/20 Deutsche Bank
- Deutsche downgrades TripAdvisor on lack of confidence in travel rebound
- 04/17/20 Jefferies
- Nordson initiated with a Buy at Jefferies
- 04/06/20 KeyBanc
- KeyBanc upgrades 'best-in-class asset' Nordson to Overweight
- 04/06/20 KeyBanc
- Nordson upgraded to Overweight from Sector Weight at KeyBanc
- 03/16/20 Wells Fargo
- Wells Fargo upgrades Nordson on 'increasingly favorable' risk/reward
- 05/19/20 CIBC
- Aurora Cannabis price target lowered to C$14 from C$27 at CIBC
- 05/19/20 MKM Partners
- Aurora Cannabis price target raised to C$18 from C$12 at MKM Partners
- 05/15/20 MKM Partners
- Aurora Cannabis price target raised to C$12 from C$1 at MKM Partners
- 05/15/20 Piper Sandler
- Aurora Cannabis upgraded to Neutral from Underweight at Piper Sandler
- 05/19/20 Benchmark
- Take-Two price target raised to $149 from $142 at Benchmark
- 05/15/20 Piper Sandler
- Piper survey finds people are playing more video games during COVID-19
- 05/12/20 Stephens
- Electronic Arts named a Best Idea at Stephens
- 04/06/20 Wells Fargo
- Take-Two initiated with an Overweight at Wells Fargo
- 01/17/20 Deutsche Bank
- CorePoint Lodging initiated with a Buy at Deutsche Bank
- 12/20/19 Stifel
- DiamondRock named top lodging REIT pick for 2020 at Stifel
- 08/16/19 Stifel
- Wyndham Hotels selloff on CorePoint comments seems overdone, says Stifel
- 07/09/19
- Fly Intel: Top five analyst downgrades
- 05/20/20 SunTrust
- SunTrust upgrades Skyline to Buy ahead of today's earnings report
- 05/20/20 SunTrust
- Skyline upgraded to Buy from Hold at SunTrust
- 04/07/20 RBC Capital
- Skyline downgraded to Sector Perform from Outperform at RBC Capital
- 04/07/20 RBC Capital
- Skyline downgraded to Sector Perform from Outperform at RBC Capital
- 03/19/20
- ZTO Express downgraded to Hold from Buy at CMB International
- 05/20/20 Morgan Stanley
- Morgan Stanley upgrades JOYY to Overweight on stepping up monetization of Likee
- 05/20/20 Morgan Stanley
- JOYY upgraded to Overweight from Equal Weight at Morgan Stanley
- 11/13/19 Nomura Instinet
- YY price target raised to $77 from $70 at Nomura Instinet
- 09/20/19 UBS
- YY upgraded to Buy from Neutral at UBS
- 05/18/20 SunTrust
- Copart price target lowered to $90 from $110 at SunTrust
- 04/23/20 JPMorgan
- Copart upgraded to Neutral on end-market resiliency at JPMorgan
- 04/23/20 JPMorgan
- Copart upgraded to Neutral from Underweight at JPMorgan
- 04/09/20 Jefferies
- Jefferies sees road congestion returning in 2021, upgrades Copart to Buy
- 04/15/20 Susquehanna
- Boot Barn downgraded to Negative at Susquehanna
- 04/15/20 Susquehanna
- Boot Barn downgraded to Negative from Neutral at Susquehanna
- 03/30/20 Craig-Hallum
- Boot Barn price target lowered to $18 from $53 at Craig-Hallum
- 03/13/20 Cowen
- Boot Barn price target lowered to $25 from $50 at Cowen
- 03/26/20 Goldman Sachs
- Huya upgraded to Buy from Neutral at Goldman Sachs
- 03/20/20 China Renaissance
- Huya upgraded to Buy on valuation at China Renaissance
- 03/20/20 China Renaissance
- Huya upgraded to Buy from Hold at China Renaissance
- 02/26/20
- Fly Intel: Top five analyst downgrades
- 05/18/20 UBS
- Galapagos price target raised to EUR 200 from EUR 194 at UBS
- 05/15/20 Barclays
- Galapagos price target raised to EUR 235 from EUR 225 at Barclays
- 05/08/20
- Galapagos downgraded to Hold from Buy at Degroof Petercam
- 03/30/20 Jefferies
- Galapagos upgraded to Buy from Hold at Jefferies
- 05/13/20 SVB Leerink
- scPharmaceuticals price target raised to $12 from $7 at SVB Leerink
- 05/13/20 H.C. Wainwright
- scPharmaceuticals price target raised to $15 from $13 at H.C. Wainwright
- 10/15/19 H.C. Wainwright
- scPharmaceuticals initiated with a Buy at H.C. Wainwright
- 05/08/20 Needham
- Flexion price target lowered to $20 from $30 at Needham
- 04/02/20 Benchmark
- Flexion price target lowered to $17 from $25 at Benchmark
- 01/06/20 Benchmark
- Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
- 12/27/19 Wells Fargo
- Flexion remains a best idea at Wells Fargo after label approval
- 03/17/20
- Fly Intel: Top five analyst downgrades
- 03/17/20 Piper Sandler
- Ruth's Hospitality downgraded to Neutral from Overweight at Piper Sandler
- 03/09/20
- Fly Intel: Top five analyst initiations
- 03/09/20 CL King
- Ruth's Hospitality initiated with a Neutral at CL King
- 05/10/20 Piper Sandler
- FLX to further strengthen Boston category leadership in LAAC, says Piper Sandler
- 04/28/20 Piper Sandler
- Untreated heart attacks negative for Abiomed, says Piper Sandler
- 04/22/20 SVB Leerink
- Boston Scientific downgraded to Market Perform at SVB Leerink on slower recovery
- 04/22/20 SVB Leerink
- Boston Scientific downgraded to Market Perform from Outperform at SVB Leerink
- 04/01/20 Goldman Sachs
- Keurig Dr Pepper resumed with a Neutral at Goldman Sachs
- 03/05/20 BofA
- Mondelez could sell Keurig Dr Pepper shares to fund M&A, says BofA
- 02/24/20
- Fly Intel: Top five analyst upgrades
- 02/24/20 Morgan Stanley
- Morgan Stanley upgrades Keurig Dr Pepper to Equal Weight after underperformance
- 05/20/20
- ZTO Express sees FY20 adjusted net income RMB5.39B-RMB5.83B
- 05/20/20
- ZTO Express reports Q1 adjusted EPS 12c, consensus 16c
- 03/16/20
- ZTO Express says Q1 parcel volume likely to exceed same quarter last year
- 03/16/20
- ZTO says COVID-19 impact on Q1 'reasonably estimable'
- 05/20/20
- JOYY sees Q2 revenue growth of 16.7%-20.2% y-o-y
- 05/20/20
- JOYY reports Q1 non-GAAP EPS 68c, consensus 56c
- 03/16/20
- YY reports Q4 EPS 96c, consensus 81c
- 05/20/20
- Take-Two sees FY21 EPS $2.60-$2.85, consensus $4.34
- 05/20/20
- Take-Two sees Q1 EPS 90c-$1.00, consensus 50c
- 05/20/20
- Take-Two reports Q4 EPS $1.07, consensus 89c
- 05/20/20
- Skyline Champion reports Q4 adjusted EPS 14c, consensus 22c
- 01/28/20
- Skyline reports Q3 adjusted EPS 32c, consensus 31c
- 05/20/20
- Shoe Carnival reports Q1 EPS ($1.16), consensus (47c)
- 03/25/20
- Shoe Carnival not providing FY20 guidance due to COVID-19 uncertainty
- 03/25/20
- Shoe Carnival reports Q4 EPS 24c, consensus 21c
- 11/21/19
- Shoe Carnival raises FY19 EPS view to $2.85-$2.89 from $2.77-$2.83
- 05/12/20
- scPharmaceuticals reports Q1 EPS (35c), consensus (54c)
- 03/24/20
- scPharmaceuticals reports Q4 EPS (58c), consensus (52c)
- 05/08/20
- Ruth's Hospitality withdraws financial guidance for 2020
- 05/08/20
- Ruth's Hospitality reports Q1 non-GAAP EPS 9c, consensus 36c
- 02/21/20
- Ruth's Hospitality reports Q4 adj. EPS 52c, consensus 50c
- 05/20/20
- Nordson withdraws FY20 guidance
- 05/20/20
- Nordson reports Q2 adjusted EPS $1.58, consensus $1.30
- 02/19/20
- Nordson reports Q1 EPS 89c, consensus $1.05
- 12/11/19
- Nordson sees FY20 GAAP EPS growth 2%--6% versus FY19
- 04/27/20
- Keurig Dr Pepper backs FY20 adjusted EPS view $1.38-$1.40, consensus $1.36
- 04/27/20
- Keurig Dr Pepper reports Q1 adjusted EPS 29c, consensus 27c
- 04/27/20
- Notable companies reporting after market close
- 03/19/20
- Keurig Dr Pepper backs FY20 adj. EPS growth 13%-15%, consensus $1.39
- 05/20/20
- Havertys reports Q1 EPS 9c vs. 17c last year
- 04/01/20
- Haverty Furniture withdraws guidance
- 03/17/20
- Havertys to temporarily close retail locations
- 02/18/20
- Haverty Furniture reports Q4 adj. EPS 40c, two estimates 35c
- 05/20/20
- Huya reports Q1 EPS 10c, consensus 13c
- 03/16/20
- Huya sees Q1 revenue RMB2.36B-RMB2.4B
- 03/16/20
- Huya reports Q4 adjusted net income per ADS 15c
- 02/20/20
- Galapagos reports Q4 revenue EURO 895.M versus EURO 317.8M last year
- 05/07/20
- Flexion reports Q1 EPS (95c), consensus (99c)
- 04/01/20
- Flexion withdraws 2020 revenue guidance
- 01/09/20
- Flexion sees FY20 product revenue $120M-$135M, consensus $133.24M
- 01/09/20
- Flexion sees Q4 revenue $23.7M, consensus $24.15M
- 05/20/20
- Expedia reports Q1 adjusted EPS ($1.83), consensus ($1.04)
- 05/20/20
- Notable companies reporting after market close
- 02/13/20
- Expedia sees Q1 adjusted EBITDA 'down substantially'
- 02/13/20
- Expedia sees being in 'double-digit' EBITDA territory in FY20
- 05/20/20
- Copart reports Q3 EPS non-GAAP 58c, consensus 66c
- 02/19/20
- Copart reports Q2 adjusted EPS 65c, consensus 66c
- 02/19/20
- Notable companies reporting after market close
- 05/20/20
- CorePoint Lodging reports Q1 AFFO 7c, two estimates 13c
- 03/12/20
- CorePoint Lodging reports Q4 adjusted FFO 17c , consensus 7c
- 04/29/20
- Boston Scientific unable to estimate overall impacts on FY20 financial results
- 04/29/20
- Boston Scientific reports Q1 adj. EPS 28c, consensus 31c
- 04/28/20
- Notable companies reporting before tomorrow's open
- 05/20/20
- Boot Barn reports Q4 adj. EPS 18c, consensus 28c
- 02/04/20
- Boot Barn backs FY20 EPS view $1.67-$1.75, consensus $1.82
- 02/04/20
- Boot Barn sees Q4 EPS 36c-38c, consensus 39c
- 05/14/20
- Aurora Cannabis reports Q3 cannabis net revenue C$69.64M vs. C$52.7M in Q2
- 04/13/20
- Aurora Cannabis reports all facilities remain fully operational
- 02/13/20
- Aurora Cannabis reports Q2 cannabis net revenue C$63.2M vs. C$70.8M in Q1
|
|
Syndicate
|
Boston Scientific… Boston Scientific announced that it has commenced concurrent offerings of $750M of shares of its common stock and $750M of shares of its Series A Mandatory Convertible Preferred Stock, subject to market and other conditions. Boston Scientific expects to grant the underwriters separate 30-day options to purchase up to an additional $112.5M of shares of Common Stock and up to an additional $112.5M of shares of Mandatory Convertible Preferred Stock. Each share of Mandatory Convertible Preferred Stock will have a liquidation preference of $100.00 per share. Unless earlier converted, each share of Mandatory Convertible Preferred Stock will automatically convert into a variable number of shares of Common Stock on or around June 1, 2023. The conversion rates, dividend rate and the other terms of the Mandatory Convertible Preferred Stock will be determined at the time of pricing. The closing of each offering is not contingent upon the closing of the other offering. J.P. Morgan and BofA Securities are acting as joint book-running managers for the offerings. ShowHide Related Items >><< - 05/15/20
- Third Point adds Disney, exits Campbell Soup in Q1
- 05/08/20
- Boston Scientific' Emblem defibrillator system meets primary endpoint
- 05/08/20
- Boston Scientific' Watchman device meets safety and efficacy endpoints
- 04/23/20
- UnitedHealth, Boston Scientific, Medtronic to deploy 3,000 ventilator devices
- 05/10/20 Piper Sandler
- FLX to further strengthen Boston category leadership in LAAC, says Piper Sandler
- 04/28/20 Piper Sandler
- Untreated heart attacks negative for Abiomed, says Piper Sandler
- 04/22/20 SVB Leerink
- Boston Scientific downgraded to Market Perform at SVB Leerink on slower recovery
- 04/22/20 SVB Leerink
- Boston Scientific downgraded to Market Perform from Outperform at SVB Leerink
- 04/29/20
- Boston Scientific unable to estimate overall impacts on FY20 financial results
- 04/29/20
- Boston Scientific reports Q1 adj. EPS 28c, consensus 31c
- 04/28/20
- Notable companies reporting before tomorrow's open
- 12/18/19
- Boston Scientific ordered to complete Channel Medsystems deal, Bloomberg reports
- 12/18/19
- Boston Scientific ordered to complete Channel Medsystems deal, Bloomberg reports
- 04/21/20
- Boston Scientific call volume above normal and directionally bullish
- 03/24/20
- Boston Scientific call volume above normal and directionally bullish
- 01/14/20
- Boston Scientific put volume heavy and directionally bearish
|
|
Syndicate
| ShowHide Related Items >><< - 05/15/20
- Third Point adds Disney, exits Campbell Soup in Q1
- 05/08/20
- Boston Scientific' Emblem defibrillator system meets primary endpoint
- 05/08/20
- Boston Scientific' Watchman device meets safety and efficacy endpoints
- 04/23/20
- UnitedHealth, Boston Scientific, Medtronic to deploy 3,000 ventilator devices
- 05/10/20 Piper Sandler
- FLX to further strengthen Boston category leadership in LAAC, says Piper Sandler
- 04/28/20 Piper Sandler
- Untreated heart attacks negative for Abiomed, says Piper Sandler
- 04/22/20 SVB Leerink
- Boston Scientific downgraded to Market Perform at SVB Leerink on slower recovery
- 04/22/20 SVB Leerink
- Boston Scientific downgraded to Market Perform from Outperform at SVB Leerink
- 04/29/20
- Boston Scientific unable to estimate overall impacts on FY20 financial results
- 04/29/20
- Boston Scientific reports Q1 adj. EPS 28c, consensus 31c
- 04/28/20
- Notable companies reporting before tomorrow's open
- 12/18/19
- Boston Scientific ordered to complete Channel Medsystems deal, Bloomberg reports
- 12/18/19
- Boston Scientific ordered to complete Channel Medsystems deal, Bloomberg reports
- 04/21/20
- Boston Scientific call volume above normal and directionally bullish
- 03/24/20
- Boston Scientific call volume above normal and directionally bullish
- 01/14/20
- Boston Scientific put volume heavy and directionally bearish
|